Peptide Tracker
Dose tracking that people actually keep using.
Peptide protocols are precise. The tools people used to follow them were not. Most tracking lived in Notes, spreadsheets, and memory. We redesigned the product around the protocol itself and shipped in under four weeks.
client
Peptide Tracker
scope
Product design, brand, App Store
shipped
May 2026 · under 4 weeks
Product strategy
Interaction design
Visual design
App Store
What it achieved
4.9★
App Store rating
Across 600+ reviews.
83%
Download to register
Of downloads complete registration.
42%
Second dose logged
Return to log again.
Challenge
People running peptide protocols had no purpose-built way to track doses, timing, and cycles. The options were generic medication reminders or spreadsheets, and a protocol only works if you actually follow it.
Strategy
Three calls shaped the product: what to build first, what the home screen serves, and what to cut.
01
Value before the account
The product proves itself before it asks for anything. Setup comes first, registration after.
02
The protocol is the product
Every screen serves the plan. No feed, no stats page, nothing that competes with following through.
03
Narrow beats complete
Everything that was not dose tracking got cut to ship in four weeks. Depth in one job over breadth in five.
01
Onboarding builds your first protocol, not your profile.
The call: setup is the product’s first win. The account ask waits until the plan exists.
video · onboarding flow
02
Logging a dose takes one tap from the home screen.
The call: build logging around the protocol, not the calendar. Faster to log, but it meant cutting the free-form journal for launch.
video · dose logging flow
03
Reminders carry the dose, so you can log without opening the app.
The call: notifications fire on the protocol’s schedule and never for engagement. Quiet by design.
video · reminders and logging
Outcome
Redesigned and shipped in under four weeks. People kept using it.
The app holds a 4.9★ rating across 600+ reviews. 83% of downloads complete registration, 42% return to log a second dose, and 78% build a full protocol. The redesign turned a generic tracker into the purpose-built tool the category was missing.
More work
